Perinatal HIV and its prevention: Progress toward an HIV-free generation

Clinics in Perinatology

Volumn 37, Issue 4, 2010, Pages 699-719

  Fowler, Mary Glenn ^a,b   Gable, Alicia R ^a   Lampe, Margaret A ^c   Etima, Monica ^b   Owor, Maxensia ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Early infant diagnosis; Epidemiology of perinatal HIV infections; Mother to child transmission of HIV 1; Resource limited settings; United States

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ANTIRETROVIRUS AGENT; EFAVIRENZ; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; EMTRICITABINE; LAMIVUDINE; LAMIVUDINE PLUS TENOFOVIR; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; NEVIRAPINE PLUS ZIDOVUDINE; TENOFOVIR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASSAY; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; CLINICAL TRIAL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; ELECTIVE SURGERY; EPIDEMIC; ETHNIC DIFFERENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFANT MORTALITY; INFECTION RISK; MATERNAL MORTALITY; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIMARY PREVENTION; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK REDUCTION; SINGLE DRUG DOSE; UNITED STATES; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS CELL INTERACTION; VIRUS RESISTANCE; VIRUS TRANSMISSION;

ANTI-RETROVIRAL AGENTS; BREAST FEEDING; EARLY DIAGNOSIS; FEMALE; FETUS; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PERINATOLOGY; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREVALENCE; UNITED STATES; UNITED STATES PUBLIC HEALTH SERVICE; WORLD HEALTH;

EID: 78349263785     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2010.09.002     Document Type: Review

References (80)

1. De Cock K.M., Fowler M.G., Mercier E., et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000, 283(9):1175-1182.
2. Simonon A., Lepage P., Karita E., et al. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. J Acquir Immune Defic Syndr 1994, 7(9):952-957.
3. Connor E.M., Sperling R.S., Gelber R., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994, 331(18):1173-1180.
4. Dorenbaum A., Cunningham C.K., Gelber R.D., et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA 2002, 288(2):189-198.
5. Cooper E.R., Charurat M., Mofenson L., et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002, 29(5):484-494.
6. Wiktor S.Z., Ekpini E., Karon J.M., et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 1999, 353(9155):781-785.
7. PETRA Study Team Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (PETRA study): a randomised, double-blind, placebo-controlled trial. Lancet 2002, 359(9313):1178-1186.
8. Jackson J.B., Musoke P., Fleming T., et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 2003, 362(9387):859-868.
9. Six Week Extended-Dose Nevirapine (SWEN) Study Team, Bedri A., Gudetta B., et al. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 2008, 372(9635):300-313.
10. Chasela C.S., Hudgens M.G., Jamieson D.J., et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010, 362(24):2271-2281.
11. Shapiro R.L., Hughes M.D., Ogwu A., et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med 2010, 362(24):2282-2294.
12. Brossard Y., Aubin J.T., Mandelbrot L., et al. Frequency of early in utero HIV-1 infection: a blind DNA polymerase chain reaction study on 100 fetal thymuses. AIDS 1995, 9(4):359-366.
13. Van Dyke R.B., Korber B.T., Popek E., et al. The Ariel Project: a prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy. J Infect Dis 1999, 179(2):319-328.
14. Kourtis A.P., Lee F.K., Abrams E.J., et al. Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis 2006, 6(11):726-732.
15. Lin H.H., Kao J.H., Hsu H.Y., et al. Least microtransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol 1996, 87(2):244-248.
16. Kaneda T., Shiraki K., Hirano K., et al. Detection of maternofetal transfusion by placental alkaline phosphatase levels. J Pediatr 1997, 130(5):730-735.
17. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999, 353(9158):1035-1039. European Mode of Delivery Collaboration.
18. The International Perinatal HIV Group The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1-a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999, 340(13):977-987.
19. Boer K., England K., Godfried M.H., et al. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in western Europe. HIV Med 2010, 11(6):368-378.
20. Ayisi J.G., van Eijk A.M., Newman R.D., et al. Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis 2004, 10(4):643-652.
21. Brahmbhatt H., Sullivan D., Kigozi G., et al. Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality. J Acquir Immune Defic Syndr 2008, 47(4):472-476.
22. Inion I., Mwanyumba F., Gaillard P., et al. Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 2003, 188(11):1675-1678.
23. Mwapasa V., Rogerson S.J., Molyneux M.E., et al. The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. AIDS 2004, 18(7):1051-1059.
24. Belyakov I.M., Berzofsky J.A. Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity 2004, 20(3):247-253.
25. Miotti P.G., Taha T.E., Kumwenda N.I., et al. HIV transmission through breastfeeding: a study in Malawi. JAMA 1999, 282(8):744-749.
26. Kourtis A.P., Jamieson D.J., de Vincenzi I., et al. Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. Am J Obstet Gynecol 2007, 197(Suppl 3):S113-S122.
27. Requena M., Bouhlal H., Nasreddine N., et al. Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins. Immunology 2008, 123(4):508-518.
28. Coutsoudis A., Pillay K., Spooner E., et al. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group. AIDS 1999, 13(12):1517-1524.
29. Iliff P.J., Piwoz E.G., Tavengwa N.V., et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 2005, 19(7):699-708.
30. Pitt J., Brambilla D., Reichelderfer P., et al. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the women and infants transmission study. J Infect Dis 1997, 175(3):567-575.
31. European Collaborative Study HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS 2001, 15(6):761-770.
32. Mackelprang R.D., John-Stewart G., Carrington M., et al. Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. J Infect Dis 2008, 197(8):1156-1161.
33. Embree J.E., Njenga S., Datta P., et al. Risk factors for postnatal mother-child transmission of HIV-1. AIDS 2000, 14(16):2535-2541.
34. Semba R.D., Kumwenda N., Hoover D.R., et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 1999, 180(1):93-98.
35. Sperling R.S., Shapiro D.E., Coombs R.W., et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996, 335(22):1621-1629.
36. Shaffer N., Roongpisuthipong A., Siriwasin W., et al. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis 1999, 179(3):590-599.
37. Semrau K., Ghosh M., Kankasa C., et al. Temporal and lateral dynamics of HIV shedding and elevated sodium in breast milk among HIV-positive mothers during the first 4 months of breast-feeding. J Acquir Immune Defic Syndr 2008, 47(3):320-328.
38. Centers for Disease Control and Prevention (CDC) HIV/AIDS surveillance report, 2007 2009, vol. 19. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta (GA), Available at:, Accessed June 16, 2010. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/.
39. Lindegren M.L., Byers R.H., Thomas P., et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 1999, 282(6):531-538.
40. McKenna M.T., Hu X. Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States. Am J Obstet Gynecol 2007, 197(Suppl 3):S10-S16.
41. Zhang X, Rhodes P, Blair J. Estimated number of perinatal HIV infections in the United States, 2005-2009. In: Programs and abstracts of the National HIV Prevention Conference 2009. Atlanta (GA), August 23-29, 2009.
42. Naver L., Lindgren S., Belfrage E., et al. Children born to HIV-1-infected women in Sweden in 1982-2003: trends in epidemiology and vertical transmission. J Acquir Immune Defic Syndr 2006, 42(4):484-489.
43. Townsend C.L., Cortina-Borja M., Peckham C.S., et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008, 22(8):973-981.
44. Warszawski J., Tubiana R., Le Chenadec J., et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French perinatal cohort. AIDS 2008, 22(2):289-299.
45. Centers for Disease Control and Prevention (CDC) Racial/ethnic disparities among children with diagnoses of perinatal HIV infection -34 states, 2004-2007. MMWR Morb Mortal Wkly Rep 2010, 59(4):97-101.
46. Burr C.K., Lampe M.A., Corle S., et al. An end to perinatal HIV: success in the US requires ongoing and innovative efforts that should expand globally. J Public Health Policy 2007, 28(2):249-260.
47. Whitmore SK, Zhang X, Taylor AW, et al. Estimated number of infants born to HIV-infected women in the United States and five dependent areas 2006 [abstract 924]. In: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections. Montréal (Canada), February 8-11, 2009.
48. Fleming P, Lindegren M, Byers R, et al. Estimated number of perinatal HIV infections, U.S., 2000. The XIV International AIDS Conference. Barcelona (Spain), July 11-16, 2002.
49. Hall H.I., Song R., Rhodes P., et al. Estimation of HIV incidence in the United States. JAMA 2008, 300(5):520-529.
50. Jamieson D.J., Cohen M.H., Maupin R., et al. Rapid human immunodeficiency virus-1 testing on labor and delivery in 17 US hospitals: the MIRIAD experience. Am J Obstet Gynecol 2007, 197(Suppl 3):S72-S82.
51. ACOG Committee on Obstetric Practice ACOG committee opinion number 304, November 2004 Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol 2004, 104(5 Pt 1):1119-1124.
52. Government of the District of Columbia Annual report 2009 update HIV/AIDS, hepatitis, STD and TB epidemiology Available at:, Accessed June 15, 2010. http://www.doh.dc.gov/hahsta.
53. Lampe MA, Thompson B, Carlson R, et al. All perinatal HIV transmission is local: using FIMR to identify and address missed prevention opportunities. abstract C16-1. In: National HIV Prevention Conference 2009. Atlanta (GA), August 23-29, 2009.
54. National Resource Center FIMR-HIV prevention methodology Available at:, Accessed October 26, 2010. http://www.fimrhiv.org/.
55. American Academy of Pediatrics (AAP) Perinatal HIV hotline. AAP News 2008, 29(12):26.
56. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States p. 1-117. Available at:, Accessed June 1, 2010. http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf.
57. Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services p. 1-161. Available at:, Accessed May 2, 2010. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
58. Newell M.L., Coovadia H., Cortina-Borja M., et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004, 364(9441):1236-1243.
59. Violari A., Cotton M.F., Gibb D.M., et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008, 359(21):2233-2244.
60. UNAIDS, World Health Organization. Epidemiology core slides - AIDS epidemic update 2009. Available at: Accessed September 26, 2010. http://data.unaids.org/pub/EPISlides/2009/2009_epiudate_core_cn.ppt.
61. World Health Organization, UNAIDS, UNICEF Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: Progress report 2009 2009, World Health Organization, Geneva (Switzerland), Available at:, Accessed May 1, 2010. http://data.unaids.org/pub/Report/2009/20090930_tuapr_2009_en.pdf.
62. US Census Bureau, Population Division, International Programs Center, Health Studies Branch HIV/AIDS surveillance data base, Table 1: HIV1 seroprevalence Available at:, Accessed October 26, 2010. http://hivaidssurveillancedb.org/hivdb/MAP/tab1.htm.
63. Spensley A., Sripipatana T., Turner A.N., et al. Preventing mother-to-child transmission of HIV in resource-limited settings: the Elizabeth Glaser Pediatric AIDS Foundation experience. Am J Public Health 2009, 99(4):631-637.
64. Shaffer N., Chuachoowong R., Mock P.A., et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999, 353(9155):773-780.
65. Leroy V., Karon J.M., Alioum A., et al. Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS 2002, 16(4):631-641.
66. Gray G.E., Urban M., Chersich M.F., et al. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS 2005, 19(12):1289-1297.
67. Dabis F., Msellati P., Meda N., et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote D'ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. Diminution de la Transmission Mere-Enfant. Lancet 1999, 353(9155):786-792.
68. Guay L.A., Musoke P., Fleming T., et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354(9181):795-802.
69. Guay L.A., Hom D.L., Kabengera S.R., et al. HIV-1 ICD p24 antigen detection in Ugandan infants: use in early diagnosis of infection and as a marker of disease progression. J Med Virol 2000, 62(4):426-434.
70. Nduati R. Breastfeeding and HIV-1 infection. A review of current literature. Adv Exp Med Biol 2000, 478:201-210.
71. Kumwenda N.I., Hoover D.R., Mofenson L.M., et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008, 359(2):119-129.
72. World Health Organization Rapid advice: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants 2009, World Health Organization, Geneva (Switzerland), p. 1-23. Available at:, Accessed May 20, 2010. http://www.searo.who.int/LinkFiles/HIV-AIDS_Rapid_Advice_MTCT%28web%29.pdf.
73. World Health Organization Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents 2009, World Health Organization, Geneva (Switzerland), p. i-25. Available at:, Accessed May 20, 2010. http://www.who.int/hiv/pub/arv/rapid_advice_art.pdf.
74. World Health Organization Rapid advice: revised WHO principles and recommendations on infant feeding in the context of HIV 2009, World Health Organization, Geneva (Switzerland), p. i-24. Available at:, Accessed May 20, 2010. http://www.searo.who.int/LinkFiles/HIV-AIDS_Rapid_Advice_Infant_feeding%28web%29.pdf.
75. World Health Organization Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2010 revision 2010, World Health Organization, Geneva (Switzerland), p. 1-145. Available at:, Accessed August 18, 2010. http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf.
76. World Health Organization Guidelines on HIV and infant feeding. Principles and recommendations for infant feeding in the context of HIV and a summary of evidence p. 1-49. Available at:, Accessed August 18, 2010. http://whqlibdoc.who.int/publications/2010/9789241599535_eng.pdf.
77. World Health Organization Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendations for a public health approach 2010, WHO, Geneva (Switzerland), p. 1-105. Available at:, Accessed August 18, 2010. http://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf.
78. World Health Organization PMTCT strategic vision 2010-2015: preventing mother-to-child transmission of HIV to reach the UNGASS and millennium development goals 2010, World Health Organization, Geneva (Switzerland).
79. World Health Organization Antiretroviral drugs for treating pregnant women and preventing HIV infection in infant: towards universal access. Recommendations for a public health approach 2006, World Health Organization, Geneva (Switzerland), p. 1-92. Available at:, Accessed May 30, 2010. http://www.who.int/hiv/pub/mtct/antiretroviral/en/index.html.
80. World Health Organization, UNICEF, UNAIDS, UNFPA HIV and infant feeding: updated based on the technical consultation held on behalf of the inter-agency team (IATT) on prevention of HIV infections in pregnant women, mothers and their infants. Geneva (Switzerland), October 25-27, 2006 2007, World Health Organization, Geneva (Switzerland), Available at:, Accessed August 18, 2010. http://www.who.int/child_adolescent_health/documents/9789241595964/en/index.html.